| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $39,543,018 ) (Continued on the next page) |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R35GM149328 | Signaling dynamics in the control of ectoderm patterning and morphogenesis | 001 | 4 | NIH | 2/17/2026 | $405,000 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01HD116852 | The role of HLA-C in chronic chorioamnionitis | 000 | 2 | NIH | 12/4/2025 | $553,485 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01HL167200 | Role of apoE in HDL-mediated enhanced survival of human regulatory T-cells | 000 | 4 | NIH | 2/16/2026 | $629,508 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01AI175431 | Pregnancy induced deacetylation of sialylated glycoproteins | 000 | 3 | NIH | 12/3/2025 | $777,106 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R33HL166441 | Intramuscular vs. Enteral Penicillin Prophylaxis to Prevent Progression of Latent Rheumatic Heart Disease: A non-inferiority randomized trial. (GOALIE) | 000 | 4 | NIH | 2/17/2026 | $643,153 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R35GM156830 | Post-transcriptional regulation of stem and progenitor cell function | 000 | 2 | NIH | 12/11/2025 | $361,125 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R35HL177125 | The microenvironment in bone marrow hematopoiesis | 000 | 2 | NIH | 2/18/2026 | $1,044,609 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01HL160569 | Microprotein Regulation of Mitochondrial Function | 000 | 5 | NIH | 2/12/2026 | $397,500 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01HL166245 | Defining PRC2 complex epigenomic control in alveolar progenitor cells | 000 | 4 | NIH | 2/11/2026 | $552,473 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R33HL166441 | Intramuscular vs. Enteral Penicillin Prophylaxis to Prevent Progression of Latent Rheumatic Heart Disease: A non-inferiority randomized trial. (GOALIE) | 001 | 4 | NIH | 2/20/2026 | $680,919 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01HL162595 | Thrombospondin1-regulated atrophy in the heart | 000 | 4 | NIH | 2/18/2026 | $577,538 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01CA278756 | Rational targeting of Cdc42 to benefit immunotherapy | 000 | 3 | NIH | 12/8/2025 | $534,962 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01HL158100 | Effect of reproductive history on longitudinal change in cardiac, vascular and lipid parameters | 000 | 5 | NIH | 2/12/2026 | $643,567 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01DK095001 | Genetic and microenvironmental regulation of macrophage functions driving biliary fibrosis in pediatric PSC | 000 | 11 | NIH | 2/19/2026 | $533,386 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | K23DC022304 | Neural Speech Tracking in Infants: Associations with Hearing, Environment, and Language | 000 | 2 | NIH | 12/4/2025 | $161,449 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | U01DK134976 | Cincinnati Children's Clinical Center for Targeting the Pathophysiology of Youth-Onset Type 2 Diabetes | 000 | 4 | NIH | 2/12/2026 | $824,771 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | T2331569 | Children's Hospitals Graduate Medical Education Payment Program | 09 | 8 | HRSA | 12/1/2025 | $1,667,084 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | T2331569 | Children's Hospitals Graduate Medical Education Payment Program | 09 | 8 | HRSA | 12/1/2025 | $1,180,352 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R21AI183058 | Systems analysis of immune responses to Norovirus infection in a human challenge model. | 000 | 2 | NIH | 12/5/2025 | $200,625 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01HL172839 | Acetylation Regulates YAP Subcellular Localization and Cardiac Regeneration | 000 | 2 | NIH | 2/9/2026 | $499,446 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | UM1TR006070 | Patient-specific, combinatorial NAMs for gastrointestinal diseases and drug response prediction | 000 | 1 | NIH | 2/9/2026 | $3,240,000 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01DK146438 | Mechanisms regulating competency of hepatocyte plasticity | 000 | 1 | NIH | 2/10/2026 | $851,275 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01HL171046 | Initiators of thrombotic microangiopathy | 000 | 3 | NIH | 2/9/2026 | $638,913 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | K12HD028827 | Child Health Research Career Development Award (K1-Renewal Yrs 31-35) | 000 | 34 | NIH | 1/30/2026 | $444,598 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01NS132504 | Advancing CNS drug delivery via epigenetic modulation | 000 | 4 | NIH | 1/31/2026 | $511,676 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | K23DK135797 | Disrupted sleep architecture in adolescents with functional abdominal pain disorders | 000 | 4 | NIH | 3/3/2026 | $190,307 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01HL171221 | Developing DWORF gene therapy to treat heart failure and muscular dystrophy | 000 | 3 | NIH | 2/23/2026 | $564,156 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01HL137766 | Molecular Mechanisms of Atrial Development and Regeneration | 000 | 8 | NIH | 2/23/2026 | $538,341 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R33HL166441 | Intramuscular vs. Enteral Penicillin Prophylaxis to Prevent Progression of Latent Rheumatic Heart Disease: A non-inferiority randomized trial. (GOALIE) | 003 | 4 | NIH | 2/24/2026 | $135,660 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | F31HL172346 | Effects of early Retinoic Acid signaling on valve development | 000 | 3 | NIH | 2/24/2026 | $42,479 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01NS124660 | Roles of Gsx factors in basal ganglia development | 001 | 5 | NIH | 2/28/2026 | $60,259 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01HL166335 | Early detection of pulmonary complications of hematopoietic stem-cell transplantation in children using hyperpolarized xenon MRI | 000 | 4 | NIH | 2/23/2026 | $670,134 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01NS120892 | Identification of Novel Pathways Causing NF1-Driven Schwann Cell Tumors | 000 | 5 | NIH | 2/24/2026 | $500,637 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01DK135478 | Organoid-guided Precision Hepatology for Steatohepatitis | 000 | 3 | NIH | 1/14/2026 | $589,780 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | K23AI175525 | Improving Anaphylaxis Outcomes Through Personalized Care Strategies | 000 | 3 | NIH | 1/15/2026 | $192,252 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01DK133145 | Diabetic Memory in Hematopoietic Stem Cells | 000 | 4 | NIH | 12/22/2025 | $436,663 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01AI181778 | Sialylated antibody defense against intracellular infections | 000 | 3 | NIH | 1/15/2026 | $642,356 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01DK134646 | RNA silencing machinery in extracellular vesicle-mediated immunometabolic regulation | 000 | 3 | NIH | 1/15/2026 | $584,778 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | F30AI188599 | Mechanisms of CD8+ T cell-induced Innate Immune Activation | 000 | 2 | NIH | 1/6/2026 | $42,747 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | F30AI181481 | Mechanisms of Longitudinal Microbial Colonization in Pediatric Atopic Dermatitis | 000 | 3 | NIH | 1/6/2026 | $48,948 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | K01DK135647 | Microbial regulation of intestinal tuft cell homeostasis | 000 | 4 | NIH | 1/6/2026 | $140,271 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01HD114702 | Food-based Randomized trial for Enhancing Support of Hospitalized children and their families (FRESH) | 000 | 2 | NIH | 1/16/2026 | $605,702 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | F31HL178081 | Characterization of Nrac, a Novel Cardiac and Adipose Enriched Microprotein | 000 | 2 | NIH | 2/20/2026 | $42,479 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | UM1AI148372 | Cincinnati Children's Hospital Medical Center Vaccine and Treatment Evaluation Units (UM1 Clinical Trial Required) | 000 | 7 | NIH | 1/7/2026 | $556,687 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | UM1AI148372 | Cincinnati Children's Hospital Medical Center Vaccine and Treatment Evaluation Units (UM1 Clinical Trial Required) | 000 | 7 | NIH | 1/7/2026 | $798,114 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | K08AI180350 | Maternal B cells enforce fetal tolerance | 000 | 3 | NIH | 12/9/2025 | $193,212 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01NS140460 | Glial Origin and Signaling in Medulloblastoma | 001 | 2 | NIH | 2/28/2026 | $60,484 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01AI124355 | Genetic and Immunological Dissection of Eosinophilic Esophagitis | 000 | 10 | NIH | 12/9/2025 | $678,808 |
| | 2026 | 2026 | CHILDRENS HOSPITAL MEDICAL CENTER | 3333 BURNET AVE | CINCINNATI | OH | 45229-3039 | HAMILTON | USA | R01AI176519 | Blocking granzyme-mediated immune suppression to enhance HIV vaccine efficacy | 000 | 4 | NIH | 1/27/2026 | $550,847 |
|
